ArticleClinical rheumatology2020
Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19.
Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes.Critical care (London, England) · 2020Pooled it
- Article
- COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort.Rheumatology (Oxford, England) · 2023Observational
- COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization.Rheumatology and therapy · 2023Article
- Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation.Frontiers in cardiovascular medicine · 2023Article
- COVID-19 and corticosteroids: a narrative review.Inflammopharmacology · 2022Review
- Hyperinflammation, apoptosis, and organ damage.Experimental biology and medicine (Maywood, N.J.) · 2022Review
- Neutrophil infiltration and myocarditis in patients with severe COVID-19: A post-mortem study.Frontiers in cardiovascular medicine · 2022Article
- Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).Experimental biology and medicine (Maywood, N.J.) · 2021Observational
- The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.Modern rheumatology · 2021Review
- Lupus anticoagulant and mortality in patients hospitalized for COVID-19.Journal of thrombosis and thrombolysis · 2021Article
- Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.International journal of rheumatic diseases · 2021Review
- Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.Journal of clinical medicine · 2021Article
- Incidence of lupus anticoagulant in hospitalized covid-19 patients.American journal of blood research · 2021Article
- Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids.Mediterranean journal of hematology and infectious diseases · 2020Article
- Differential Diagnosis and Hospital Emergency Management for Fastlane Treatment of Central Nervous System Infection Under the COVID-19 Epidemic in Changsha, China.Frontiers in neurology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.